XBiotech Inc.
XBIT
$2.92
-$0.06-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 86.50% | -8.82% | -126.71% | 31.90% | -48.78% |
| Total Depreciation and Amortization | 0.92% | 2.31% | 1.15% | 1.62% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -418.76% | 55.12% | 945.80% | -116.93% | 325.36% |
| Change in Net Operating Assets | -748.09% | 67.16% | -190.35% | -127.07% | 194.93% |
| Cash from Operations | 47.35% | 6.69% | -90.50% | -293.07% | -26.44% |
| Capital Expenditure | 91.87% | 63.14% | 26.96% | -924.24% | -201.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 91.87% | 63.14% | 26.96% | -100.55% | -201.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 1,180.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -201.94% | -- | 1,180.00% | 442.86% |
| Foreign Exchange rate Adjustments | 656.14% | 117.95% | -397.10% | 145.79% | -539.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.35% | -1,751.57% | -381.60% | -109.20% | -37.57% |